title: [Chronic heart failure and osteoporosis].
abstract: Osteoporosis (OP) and chronic heart failure (CHF) are chronic noninfection diseases which are characterized not only by high prevalence but also by development of severe complications such as fractures in OP and decompensation in CHF. These complications lead to loss of functional, social activity and independent way of life, worsening of quality of life, hospitalizations, and premature death of a patient. During many years OP and CHF have been looked upon as independent diseases but according to recent data risk factors of their development and progression are common. In this article we pay special attention to mechanisms of development of CHF and OP, their risk factors, instrumental and laboratory diagnosis of OP, and problems of its treatment.
authors: V N
authors: VN
authors: Larina
authors: B Ia
authors: BIa
authors: Bart
authors: T N
authors: TN
authors: Raspopova
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D019468:Disease Management; D018450:Disease Progression; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D054539:Medication Therapy Management; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology
chemical_list: D050071:Bone Density Conservation Agents; D002317:Cardiovascular Agents